A Closer Look at 7 Analyst Recommendations For NovoCure
A Closer Look at 7 Analyst Recommendations For NovoCure
对NovoCure的7项分析师建议进行详细分析
7 analysts have shared their evaluations of NovoCure (NASDAQ:NVCR) during the recent three months, expressing a mix of bullish and bearish perspectives.
最近三个月，有7位分析师对NovoCure（纳斯达克股票代码：NVCR）进行了评估，表达了看好和看淡的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have recently evaluated NovoCure and provided 12-month price targets. The average target is $25.29, accompanied by a high estimate of $42.00 and a low estimate of $17.00. This current average has decreased by 3.36% from the previous average price target of $26.17.
分析师最近对NovoCure进行了评估，并提供了为期12个月的目标股价。平均目标价格为25.29美元，高估值为42.00美元，低估值为17.00美元。这个当前的平均目标价格比之前的26.17美元的平均目标价格下降了3.36％。
Deciphering Analyst Ratings: An In-Depth Analysis
分析师评级解读：深入分析
A comprehensive examination of how financial experts perceive NovoCure is derived...
对综合了近期分析师行动...
登录免费看全文
登录/注册